The Trurat Show

Animals used in safety pharmacology studies inform the decision to progress new drugs further in the drug development process towards the clinic. The temperature and activity of these animals are recorded to monitor their welfare and the effects of the study compound. Behaviour is monitored by trained scientists using singly housed animals, often held in bespoke cages. Behavioural analysis generally requires manual observation by experienced observers, usually limited to ‘snapshots’ during the light phase when rats are less active (e.g. FOB, Irwin test).  Body temperature can be measured manually at intervals, or continuously using surgically implanted telemetry transducers.  These conventional approaches are not always compatible with 24 h continuous monitoring or with being performed concurrently in a repeat-dose study. 

The Rodent Big Brother system developed by Actual Analytics Ltd will provide an unobtrusive technology that can be incorporated into standard IVC racks rather than as a bench top system. This technology will avoid the need for surgery or single housing, reduce the number of animals needed for a study, deliver welfare benefits to the animals used and, through the incorporation of additional measurements into existing study types reduce the number of studies needed overall.

Full details about this CRACK IT Challenge can be found on the CRACK IT website.

Redfern WS et al. (2017). Automated recording of home cage activity and temperature of individual rats housed in social groups: The Rodent Big Brother project. PLoS ONE

Tse K et al. (2015). Rodent Big Brother: A home cage automated behavioural monitoring system for safety pharmacology toxicology studies. Safety Pharmacology Society 15th Annual Meeting, Prague, Czech Republic.

Redfern WS et al. (2014). Rodent Big Brother: Development and validation of a home cage automated behavioural monitoring system for use in repeat-dose toxicity studies in rats. Eurotox  50th Congress, Edinburgh, UK. Toxicology Letters 229: S47-48. 1016/j.vascn.2015.08.012.

Redfern WS et al. (2013). Functional Assessments in Repeat-dose Toxicity Studies: The Art of the Possible. Toxicology Research 2: 209-234.doi 10.1039/C3TX20093K


Karen Tse, Amy Keerie, Rowland Sillito, Rachel Collier, Mark Pilling, Catherine Vickers, Kathryn Chapman, J Douglas Armstrong, William S Redfern. (2015). Continuous monitoring of individual rats when group-housed in the home cage to assess drug-induced changes in activity and temperature. 

Karen Tse, Amy Keerie, Rowland Sillito, Rachel Collier, Claire Grant, Catherine Vickers, Kathryn Chapman, J Douglas Armstrong, Will S Redfern. (2015). Rodent Big Brother: A Comparison to the Modified Irwin Test for Assessing Drug-Induced Changed in Activity and Temperature in Rats.

Karen Tse, Amy Keerie, Agisilaos Chartsias, Rowland Sillito, John Pedersen, Stephanie Klein, Catherine Vickers, Kathryn Chapman, J Douglas Armstrong, Will S Redfern. (2015). Rodent Big Brother: Optimal Location and Orientation of the Subcutaneous RFID microchip Transponder for Home Cage 24/7 Monitoring in Rats.

In collaboration with AstraZeneca and Actual Analytics, we hosted a one-day workshop in central London on 5 June 2017 to showcase the rodent home cage behavioural monitoring system, the Home Cage Analyser (HCA), developed by Actual Analytics through the Rodent Big Brother (RBB) CRACK IT Challenge. A report summarising the outputs of the workshop can be downloaded here.

The HCA provides continual, minimally-invasive, 24/7 automated monitoring of individual rat’s ambulatory activty, behaviour and temperature while group-housed in a standard, unmodified home cage. Benefits of the system include improved animal welfare, improved data quality and a reduction in animal numbers.

The workshop brought together individuals from the pharmaceutical industry, contract research organisations and international regulatory agencies with the aims of:

  • Providing background on the development, validation and application of the HCA.

  • Identifying the opportunities and barriers to using home cage monitory systems on preclinical safety studies.

  • Agreeing a strategy to facilitate the uptake and application of home cage behavioural monitoring systems on preclinical safety studies to maximise the scientific and 3Rs benefits of the system.

The workshop included presentations from AstraZeneca describing the RBB Challenge and validation of the HCA, as well as showcasing some of the proof-of-concept work using the system to investigate the full behavioural profile of two drugs. Actual Analytics presented on the technical development of the HCA. These presentations, containing audio commentary, can be accessed below.   

Working Group

To support the wider uptake of the HCA system, it was agreed at the workshop that the NC3Rs, acting as an honest broker, should convene a working group to define and carry out an international, inter-company validation study. The working group is currently in the process of being formed to define the scope of the study and what information/data would need to be shared by working group members to support this. If you are interested in being part of the working group please contact us at by 31 October 2017.

Further information about the HCA

If you are interested in the HCA system visit the Actual Analytics website or contact Actual Analytics at

Back to top